The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation

Abstract Increased galectin-3 plasma concentration has been linked to an unfavorable outcome in patients with heart failure or atrial fibrillation (AF). There are no published data about the prognostic utility of galectin-3 and high-sensitivity C-reactive protein (hs-CRP) for long-term clinical outc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Milan Pavlović, Svetlana Apostolović, Dragana Stokanović, Stefan Momčilović, Tatjana Jevtović-Stoimenov, Snezana Ćirić Zdravković, Sonja Šalinger Martinović, Nebojsa Krstić, Goran Koraćević, Danijela Djordjevic, Vladan Ćosić, Valentina N. Nikolic
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a25522139e604c12a66fa61232782ca5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a25522139e604c12a66fa61232782ca5
record_format dspace
spelling oai:doaj.org-article:a25522139e604c12a66fa61232782ca52021-12-02T15:06:20ZThe Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation10.1038/s41598-017-15265-02045-2322https://doaj.org/article/a25522139e604c12a66fa61232782ca52017-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-15265-0https://doaj.org/toc/2045-2322Abstract Increased galectin-3 plasma concentration has been linked to an unfavorable outcome in patients with heart failure or atrial fibrillation (AF). There are no published data about the prognostic utility of galectin-3 and high-sensitivity C-reactive protein (hs-CRP) for long-term clinical outcome in the Non-ST elevation acute myocardial infarction (NSTEMI) patients with preexisting AF. Thirty-two patients with the first acute NSTEMI and preexisting AF and 22 patients without preexisting AF, were prospectively followed for fifteen months. Patients with AF had significantly higher galectin-3 plasma levels (p < 0.05) and hs-CRP concentration (p < 0.01), compared with patients without AF. Galectin-3 plasma concentration was not a significant covariate of the composite outcomes (p = 0.913). Patients with high hs-CRP (above 4.55 mg/L) showed 2.5 times increased risk (p < 0.05) of the composite outcome occurrence (p < 0.05). Besides, three-vessel coronary artery disease, creatinine serum level, and creatinine clearance were significant covariates (p < 0.05; p < 0.05; p < 0.01) of the composite outcome, respectively. Creatinine clearance, solely, has been shown to be an independent predictor of unfavorable prognosis after a 15-month follow-up. Galectin-3 and hs-CRP plasma levels were elevated in NSTEMI patients with AF, but with differential predictive value for an unfavorable clinical outcome. Only hs-CRP was associated with increased risk of composite outcome occurrence.Milan PavlovićSvetlana ApostolovićDragana StokanovićStefan MomčilovićTatjana Jevtović-StoimenovSnezana Ćirić ZdravkovićSonja Šalinger MartinovićNebojsa KrstićGoran KoraćevićDanijela DjordjevicVladan ĆosićValentina N. NikolicNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Milan Pavlović
Svetlana Apostolović
Dragana Stokanović
Stefan Momčilović
Tatjana Jevtović-Stoimenov
Snezana Ćirić Zdravković
Sonja Šalinger Martinović
Nebojsa Krstić
Goran Koraćević
Danijela Djordjevic
Vladan Ćosić
Valentina N. Nikolic
The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
description Abstract Increased galectin-3 plasma concentration has been linked to an unfavorable outcome in patients with heart failure or atrial fibrillation (AF). There are no published data about the prognostic utility of galectin-3 and high-sensitivity C-reactive protein (hs-CRP) for long-term clinical outcome in the Non-ST elevation acute myocardial infarction (NSTEMI) patients with preexisting AF. Thirty-two patients with the first acute NSTEMI and preexisting AF and 22 patients without preexisting AF, were prospectively followed for fifteen months. Patients with AF had significantly higher galectin-3 plasma levels (p < 0.05) and hs-CRP concentration (p < 0.01), compared with patients without AF. Galectin-3 plasma concentration was not a significant covariate of the composite outcomes (p = 0.913). Patients with high hs-CRP (above 4.55 mg/L) showed 2.5 times increased risk (p < 0.05) of the composite outcome occurrence (p < 0.05). Besides, three-vessel coronary artery disease, creatinine serum level, and creatinine clearance were significant covariates (p < 0.05; p < 0.05; p < 0.01) of the composite outcome, respectively. Creatinine clearance, solely, has been shown to be an independent predictor of unfavorable prognosis after a 15-month follow-up. Galectin-3 and hs-CRP plasma levels were elevated in NSTEMI patients with AF, but with differential predictive value for an unfavorable clinical outcome. Only hs-CRP was associated with increased risk of composite outcome occurrence.
format article
author Milan Pavlović
Svetlana Apostolović
Dragana Stokanović
Stefan Momčilović
Tatjana Jevtović-Stoimenov
Snezana Ćirić Zdravković
Sonja Šalinger Martinović
Nebojsa Krstić
Goran Koraćević
Danijela Djordjevic
Vladan Ćosić
Valentina N. Nikolic
author_facet Milan Pavlović
Svetlana Apostolović
Dragana Stokanović
Stefan Momčilović
Tatjana Jevtović-Stoimenov
Snezana Ćirić Zdravković
Sonja Šalinger Martinović
Nebojsa Krstić
Goran Koraćević
Danijela Djordjevic
Vladan Ćosić
Valentina N. Nikolic
author_sort Milan Pavlović
title The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
title_short The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
title_full The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
title_fullStr The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
title_full_unstemmed The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation
title_sort association between galectin-3 and hs-crp and the clinical outcome after non-st-elevation myocardial infarction with preexisting atrial fibrillation
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a25522139e604c12a66fa61232782ca5
work_keys_str_mv AT milanpavlovic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT svetlanaapostolovic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT draganastokanovic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT stefanmomcilovic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT tatjanajevtovicstoimenov theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT snezanaciriczdravkovic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT sonjasalingermartinovic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT nebojsakrstic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT gorankoracevic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT danijeladjordjevic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT vladancosic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT valentinannikolic theassociationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT milanpavlovic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT svetlanaapostolovic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT draganastokanovic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT stefanmomcilovic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT tatjanajevtovicstoimenov associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT snezanaciriczdravkovic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT sonjasalingermartinovic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT nebojsakrstic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT gorankoracevic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT danijeladjordjevic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT vladancosic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
AT valentinannikolic associationbetweengalectin3andhscrpandtheclinicaloutcomeafternonstelevationmyocardialinfarctionwithpreexistingatrialfibrillation
_version_ 1718388534228811776